Nascent Biotech Inc. Quarterly Common Stock, Shares, Issued from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Nascent Biotech Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q1 2014 to Q2 2024.
  • Nascent Biotech Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 172M shares, a 19.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 172M +28.6M +19.9% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 171M +38.8M +29.5% Mar 31, 2024 10-Q 2024-08-14
Q4 2023 169M +46.7M +38.3% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 167M +48.5M +41.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 144M +26.6M +22.7% Jun 30, 2023 10-Q 2023-08-18
Q1 2023 132M +20.5M +18.4% Mar 31, 2023 10-K 2024-07-01
Q4 2022 122M +14.3M +13.3% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 118M +10.5M +9.72% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 117M +9.34M +8.67% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 111M +6.48M +6.18% Mar 31, 2022 10-K/A 2023-07-03
Q4 2021 108M +16.4M +18% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 108M +40.5M +60.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 108M +44.9M +71.6% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 105M +59.9M +134% Mar 31, 2021 10-K 2022-06-15
Q4 2020 91.3M +55.4M +154% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 67.2M +33.4M +98.9% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 62.8M +29.3M +87.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 44.9M +12.2M +37.5% Mar 31, 2020 10-K 2021-07-08
Q4 2019 36M +4.82M +15.5% Dec 31, 2019 10-Q 2020-02-11
Q3 2019 33.8M +3.24M +10.6% Sep 30, 2019 10-Q 2019-11-18
Q2 2019 33.5M +4.95M +17.4% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 32.6M +4.89M +17.6% Mar 31, 2019 10-K 2020-06-22
Q4 2018 31.1M +3.88M +14.2% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 30.5M +3.4M +12.5% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 28.5M +4.5M +18.7% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 27.8M +4.46M +19.2% Mar 31, 2018 10-K 2019-07-12
Q4 2017 27.3M +5.38M +24.6% Dec 31, 2017 10-Q 2018-01-31
Q3 2017 27.1M +5.29M +24.2% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 24M +2.26M +10.4% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 23.3M +1.67M +7.75% Mar 31, 2017 10-K 2018-06-29
Q4 2016 21.9M +477K +2.23% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 21.8M +884K +4.22% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 21.8M +3.72M +20.6% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 21.6M +4.05M +23.1% Mar 31, 2016 10-K 2017-06-29
Q4 2015 21.4M +4.09M +23.6% Dec 31, 2015 10-Q 2016-02-19
Q3 2015 21M Sep 30, 2015 10-Q 2015-11-05
Q2 2015 18.1M Jun 30, 2015 10-Q 2015-07-30
Q1 2015 17.6M +10.6M +151% Mar 31, 2015 10-K 2016-07-14
Q4 2014 17.3M Dec 31, 2014 10-Q 2015-02-13
Q1 2014 7M Mar 31, 2014 10-K 2015-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.